Dr. Harry Neuwirth, MD

Dr. Neuwirth practices at Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services.

Dr. Neuwirth's NPI, 1326067919, was assigned on July 18, 2006. Dr. Neuwirth graduated from The Johns Hopkins University School of Medicine in 1981. Dr. Neuwirth holds California license C41137.

Dr. Neuwirth's primary practice is Presbyterian Hospital, at 1100 Central Avenue SE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 724-8386.

Dr. Neuwirth's primary practice is Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services. Dr. Neuwirth is also affiliated with MarinHealth Medical Center. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Neuwirth to 2 more hospitals, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Neuwirth practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Neuwirth's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Neuwirth is board certified in urology by the American Board of Urology. Dmand AI has Dr. Neuwirth's licenses on file in 3 states: California, Iowa and Maryland.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney removal surgery, kidney stone disease, prostate cancer and prostate inflammation or infection among the conditions Dr. Neuwirth treats.

CMS data shows 1,616 Medicare services from Dr. Neuwirth across 13 procedure codes in 2024, for 612 Medicare patients. Medicare paid $116,576 for them.

CMS counts 612 Medicare patients who saw Dr. Neuwirth in 2024. The largest group is 75 to 84, with 279 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Neuwirth's median patient age at 72, with 16% women.

In 2024, Dr. Neuwirth wrote 608 Medicare Part D claims for 210 patients. 94% of them were for generic drugs. CMS names the drug for 489 of them, across 9 drugs with 11 or more claims each, at $29,267 in total drug cost. In 2023, CMS named 436 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Neuwirth for performance year 2024.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Neuwirth. The most frequent topics are Prostatic Neoplasms, DNA, Neoplasm and Prostatectomy. Dr. Neuwirth has published most often in J Urol. Dr. Neuwirth's most frequent co-authors are Robert Lawrence Cohen, MD, Jean Dekernion, MD and Armando E. Giuliano, FACS, MD.

CMS Open Payments shows 213 general payments to Dr. Neuwirth from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 67% of the total. Boston Scientific Corporation paid the most, $1,356.

Dmand AI lists 1 award for Dr. Neuwirth, most recently Regional Top Doctor in 2014.

Dr. Neuwirth graduated from The Johns Hopkins University School of Medicine in 1981.

Dr. Neuwirth is in network with 9 carriers, including United Healthcare, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.